NFATc1 Regulates PD-1 Expression upon T Cell Activation

Cited by (415)

Items 201–300 of 415

1. Control of Regulatory T Cells by Co-signal Molecules
   James B. Wing, Christopher Tay, Shimon Sakaguchi · 2019 · Advances in experimental medicine and biology
2. Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity
   Zhongyi Jiang, Haitao Zhu, Pusen Wang, Weitao Que, Lin Zhong, Xiao‐Kang Li, Futian Du · 2022 · MedComm
3. Immune Checkpoint Blockade in Breast Cancer Therapy
   Xia Bu, Yihui Yao, Xiaoyü Li · 2017 · Advances in experimental medicine and biology
4. Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
   Grace Mallett, Arian D. J. Laurence, Shoba Amarnath · 2019 · International Journal of Molecular Sciences
5. An Anti-Programmed Death-1 Antibody (αPD-1) Fusion Protein That Self-Assembles into a Multivalent and Functional αPD-1 Nanoparticle
   Peng Zhao, Djordje Atanackovic, Shuyun Dong, Hideo Yagita∥, Xiao He, Mingnan Chen · 2017 · Molecular Pharmaceutics
6. Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory
   Hyun Mu Shin, Varun N. Kapoor, Gwanghun Kim, Peng Li, Hang‐Rae Kim, M. Suresh, Susan M. Kaech, E. John Wherry, Liisa Kaarina Selin, Warren J. Leonard et al. · 2017 · PLoS Pathogens
7. Therapeutic targeting of immune checkpoints with small molecule inhibitors.
   Wade M Smith, Ian J. Purvis, Colin N Bomstad, Collin M. Labak, Kiran Kumar Velpula, Andrew J. Tsung, Jenna N. Regan, Sujatha Venkataraman, Rajeev Vibhakar, Swapna Asuthkar · 2019 · Europe PMC (PubMed Central)
8. Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression
   Man‐Chin Chen, Christian Ronquillo Pangilinan, Che‐Hsin Lee · 2019 · Cancers
9. A Candidate Gene Analysis of Canine Hypoadrenocorticism in 3 Dog Breeds
   Andrea D. Short, Alisdair M. Boag, Briän Catchpole, Lorna J. Kennedy, Jonathan Massey, S. Rothwell, Eystein S. Husebye, William Ollier · 2013 · Journal of Heredity
10. A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
    Ching‐Tse Wu, Cheng‐I Chu, Feng‐Yu Wang, Huiyu Yang, Wei-Sung Tseng, Chuang‐Rung Chang, Chien‐Chung Chang · 2022 · Cell & Bioscience
11. VMP1 prevents Ca2+ overload in endoplasmic reticulum and maintains naive T cell survival
    Ying Liu, Yuying Ma, Jing Xu, Guangyue Zhang, Xiaocui Zhao, Zihao He, Lixia Wang, Na Yin, Min Peng · 2023 · The Journal of Experimental Medicine
12. PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
    Hyesuk Yoon, Jeremy M. Boss · 2010 · The Journal of Immunology
13. Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment
    Manel Albertí‐Valls, Sara Olave, Anna Olomí, Anna Macià, Núria Eritja · 2024 · Cancers
14. Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation
    Haoting Hsu, Sarah Boudová, Godfrey Mvula, Titus Henry Divala, Randy George Mungwira, Chris R. Harman, Miriam K. Laufer, C. David Pauza, Cristiana Cairo · 2016 · The Journal of Immunology
15. Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms
    Jen Chin C. Wang, Chi Chen, Ajay Kundra, Sreenath Kodali, Anita Pandey, Ching Wong, Tony Cheung, Vladimir K. Gotlieb, Gardith Joseph, Sophia Tribie · 2019 · Leukemia Research
16. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer
    Ward Celus, Ana Isabel Oliveira, Silvia Rivis, Heleen H. Van Acker, Ewout Landeloos, Jens Serneels, Sarah Trusso Cafarello, Yannick Van Herck, Roberta Mastrantonio, Arnaud Köhler et al. · 2021 · Cancer Immunology Research
17. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
    Xinying Li, Guannan Wu, Cen Chen, Yuan Zhao, Suhua Zhu, Xincui Song, Jie Yin, Tangfeng Lv, Yong Song · 2021 · Frontiers in Immunology
18. The expression of PD-1 and its ligands increases in Leishmania infection and its blockade reduces the parasite burden
    Abdollah Jafarzadeh, Sunil Kumar, Neelam Prakash Bodhale, Sara Jafarzadeh, Maryam Nemati, Iraj Sharifi, Arup Sarkar, Bhaskar Saha · 2022 · Cytokine
19. Receptor signaling, transcriptional, and metabolic regulation of T cell exhaustion
    Mumtaz Yaseen Balkhi · 2020 · OncoImmunology
20. Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants
    Young Jun Shim, Raneem Khedraki, Jayeeta Dhar, Ran Fan, Nina Dvorina, Anna Valujskikh, Robert L. Fairchild, William M. Baldwin · 2020 · Kidney International
21. The Effect of Adjuvanting Cancer Vaccines with Herpes Simplex Virus Glycoprotein D on Melanoma-Driven CD8+ T Cell Exhaustion
    Ying Zhang, Hildegund C.J. Ertl · 2014 · The Journal of Immunology
22. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma
    Siri Tähtinen, C Blattner, Markus J. V. Vähä-Koskela, Dipongkor Saha, Mikko Siurala, Suvi Parviainen, Jochen Sven Utikal, Anna Kanerva, Viktor Umansky, Akseli Hemminki · 2016 · Journal of Immunotherapy
23. Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity
    Su Hwan Park, J.H. Lee, Hye Jin Yun, Seok-Ho Kim, Jong‐Ho Lee · 2024 · Annals of Laboratory Medicine
24. Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory
    Alexander P. R. Bally, Yan Tang, Joshua T. Lee, Benjamin G. Barwick, Ryan J. Martinez, Brian D. Evavold, Jeremy M. Boss · 2016 · The Journal of Immunology
25. Single-cell transcriptomic landscape deciphers olfactory neuroblastoma subtypes and intra-tumoral heterogeneity
    Jingyi Yang, Xiaole Song, Huankang Zhang, Quan Liu, Ruoyan Wei, Luo Guo, Cuncun Yuan, Chen Fu, Kai Xue, Yuting Lai et al. · 2024 · Nature Cancer
26. Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms
    Daniel Sungchul Choi, Douglas A. Tremblay, Camelia Iancu‐Rubin, John O Mascarenhas · 2017 · Annals of Hematology
27. GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
    Dawei Rong, Yuliang Wang, Li Liu, Hengsong Cao, Tian Huang, Hanyuan Liu, Xiaopei Hao, Guangshun Sun, Guoqiang Sun, Zhiying Zheng et al. · 2023 · Journal for ImmunoTherapy of Cancer
28. Minocycline attenuates HIV ‐1 infection and suppresses chronic immune activation in humanized NOD /LtsZ‐scid IL ‐2Rγnull mice
    Maneesh Singh, Pratibha Singh, Dolorès Vaira, Mathieu Amand, Souad Rahmouni, Michel P. Moutschen · 2014 · Immunology
29. Divergent SATB 1 expression across human life span and tissue compartments
    Simone Nüssing, Hui‐Fern Koay, Sneha Ashok Sant, Thomas Loudovaris, Stuart I. Mannering, Martha Lappas, Yves d’Udekem, Igor E. Konstantinov, Stuart P. Berzins, Guus F. Rimmelzwaan et al. · 2019 · Immunology and Cell Biology
30. Development of Cancer Immunotherapy Targeting the PD-1 Pathway
    Naomi Kamimura, Alexander Martin Wolf, Yoshiko Iwai · 2019 · Journal of Nippon Medical School
31. Salmonella impairs CD8 T cell response through PD-1: PD-L axis
    Marcela López‐Medina, Ismael Carrillo‐Martin, Jessica P. Leyva‐Rangel, Celia Mercedes Alpuche-Aranda, Vianney Francisco Ortiz-Navarrete · 2015 · Immunobiology
32. Different Induction of PD-L1 (CD274) and PD-1 (CD279) Expression in THP-1-Differentiated Types 1 and 2 Macrophages
    Chun-Yi Lai, Po‐Chun Tseng, Chia‐Ling Chen, Rahmat Dani Satria, Yung-Ting Wang, Chiou‐Feng Lin · 2021 · Journal of Inflammation Research
33. EGCG suppresses PD-1 expression of T cells via inhibiting NF-κB phosphorylation and nuclear translocation
    Zhongda Li, Fangfang Liu, Yanqiao Zeng, Yingnan Liu, Wenhe Luo, Feng Yuan, Qi Li, Qi Li, Jiaxin Chen, Mayumi Fujita et al. · 2024 · International Immunopharmacology
34. Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD
    Yewei Wang, Md Ashik Ullah, Olivia G. Waltner, Shruti S. Bhise, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R.W. Legg, Tomoko Sekiguchi, Ethan L. Nelson, Rachel D. Kuns et al. · 2024 · Journal of Clinical Investigation
35. Satb1: Restraining PD1 and T Cell Exhaustion
    Briana G. Nixon, Ming O. Li · 2017 · Immunity
36. Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications
    Janna Krueger, Christopher E. Rudd, Alison Taylor · 2019 · Seminars in Immunology
37. H3K4me3 mediates the NF-κB p50 homodimer binding to thepdcd1promoter to activate PD-1 transcription in T cells
    Priscilla S. Redd, Chunwan Lu, John David Klement, Mohammed L. Ibrahim, Gang Zhou, Takumi Kumai, Esteban Celis, Kebin Liu · 2018 · OncoImmunology
38. PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity
    Elham Ben Saad, Andres Oroya, Nikhil Ponnoor Anto, Meriem Bachais, Christopher E. Rudd · 2024 · Cell Reports
39. The molecular signature of murine T cell homeostatic proliferation reveals both inflammatory and immune inhibition patterns
    Karen A. Fortner, Jeffrey P. Bond, James W. Austin, Jeremy M. Boss, Ralph C. Budd · 2017 · Journal of Autoimmunity
40. Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
    Selena Viganó, Sara Bobisse, George Coukos, Matthieu Perreau, Alexandre Harari · 2020 · Frontiers in Immunology
41. Glucocorticoid and PD-1 Cross-Talk: Does the Immune System Become Confused?
    Sabrina Adorisio, Lorenza Cannarile, Domenico Vittorio Delfino, Emira Ayroldi · 2021 · Cells
42. PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity
    Yiqing Feng, Gordafaried Deyanat‐Yazdi, Kristin Newburn, Scott C. Potter, Mark A. Wortinger, Miriam Ramirez, Stephanie M.E. Truhlar, Pia P. Yachi · 2024 · Journal of Autoimmunity
43. Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1
    Yuwei Hao, Matthew Cook · 2022 · Frontiers in Immunology
44. Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers
    Dong Yeul Lee, Talha Salahuddin, Jabed Iqbal · 2023 · Current Oncology
45. Epigenetic and Genetic Regulation of PDCD1 Gene in Cancer Immunology
    Alok Mishra, Mukesh Verma · 2018 · Methods in molecular biology
46. Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4
    Jing Guo, Zhonghui Xue, Lie Wang · 2022 · Cellular and Molecular Immunology
47. CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes
    María Jiménez-Fernández, Cristina Rodrı́guez, Laia Cañes, Carme Ballester‐Servera, Alicia Vara, Silvia Requena, Hortensia de la Fuente, José Martínez‐González, Francisco Sánchez‐Madrid · 2022 · Cellular and Molecular Life Sciences
48. STAT5 interferes with PD-1 transcriptional activation and affects CD8+ T-cell sensitivity to PD-1-dependent immunoregulation
    Guanning Wang, Masaki Tajima, Tasuku Honjo, Akio Ohta · 2021 · International Immunology
49. T-Cell Costimulatory Blockade in Organ Transplantation
    Jonathan S. Maltzman, Laurence A. Turka · 2013 · Cold Spring Harbor Perspectives in Medicine
50. Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing
    Maria Silvia Roman Azcona, Gianni Monaco, Melissa Whitehead, Masako Monika Kaufmann, Jamal Alzubi, Toni Cathomen, Claudio Mussolino · 2025 · Molecular Therapy — Nucleic Acids
51. The transcription factor Eomes promotes expression of inhibitory receptors on hepatic CD8 + T cells during HBV persistence
    Linyan Yu, Yun Guan, Lei Li, Nan Lü, Cai Zhang · 2022 · FEBS Journal
52. Long Noncoding RNA lncNDEPD1 Regulates PD-1 Expression via miR-3619-5p in CD8+ T Cells
    Shaoyan Cheng, Feng Li, Haiming Qin, Yu Ping, Qitai Zhao, Qun Gao, Mengjia Song, Jiao Qu, Jiqi Shan, Kai Zhang et al. · 2022 · The Journal of Immunology
53. Exploring the Role of PD-1 in the Autoimmune Response: Insights into Its Implication in Systemic Lupus Erythematosus
    Nefertari Sagrero‐Fabela, Ramón Chávez-Mireles, Diana Celeste Salazar‐Camarena, Claudia Azucena Palafox‐Sánchez · 2024 · International Journal of Molecular Sciences
54. Immunocyte‐Derived Nanodrugs for Cancer Therapy
    Xiaoyu Zhu, Tianyu Wang, Hao‐Ran Jia, Fu‐Gen Wu · 2022 · Advanced Functional Materials
55. Common distal elements orchestrate CIITA isoform-specific expression in multiple cell types
    Sarah Lohsen, P Majumder, Christopher D. Scharer, Benjamin G. Barwick, J W Austin, Wendy M. Zinzow-Kramer, Jeremy M. Boss · 2014 · Genes and Immunity
56. Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen
    Emmeloes de Mare-Bredemeijer, Xiaolei Shi, Shanta Mancham, Rogier van Gent, Marieke van der Heide‐Mulder, Renate de Boer, Mirjam H.M. Heemskerk, Jeroen de Jonge, Luc J. W. van der Laan, Herold Johnny Metselaar et al. · 2015 · The Journal of Immunology
57. The Transcription Factor NFAT1 Participates in the Induction of CD4⁺T Cell Functional Exhaustion during Plasmodium yoelii Infection
    Ames, Rachel Y., Ting, Li-Min, Gendlina, Inessa, Kim, Kami, Macian, Fernando · 2017 · Infection and Immunity
58. Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response
    Hung-Chia Hsieh, Ming-Jer Young, Kuan‐Yu Chen, Wu‐Chou Su, Chien‐Chung Lin, Yi‐Ting Yen, Jan‐Jong Hung, Yi‐Ching Wang · 2025 · Science Advances
59. IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression
    Thibault Hirsch, Damien Neyens, Céline Duhamel, Alexandre Bayard, Christophe Vanhaver, Mathieu Luyckx, Francisco Sala de Oyanguren, Claude Wildmann, Nicolas Dauguet, Jean-Luc Squifflet et al. · 2024 · Cell Reports
60. CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype
    Binle Tian, Zhilong Wang, Mei Cao, Na Wang, Xuebing Jia, Yuanyuan Zhang, Jingyi Zhou, Sijia Liu, Wen Zhang, Xiao Dong et al. · 2025 · Journal of Experimental & Clinical Cancer Research
61. Unlocking the mystery of the PD-1/PD-L1 axis: beyond the checkpoint hype
    Pierre-Hubert Desimpel, Pierre-Florent Petit, Benoit J. Van den Eynde, Jingjing Zhu · 2025 · Frontiers in Immunology
62. The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes
    Bartłomiej Kuszczak, Tomasz Wróbel, Katarzyna Wicherska‐Pawłowska, Justyna Rybka · 2023 · International Journal of Molecular Sciences
63. Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD
    Ying Wang, Shan He, Gennaro Calendo, Tien Bui, Yuanyuan Tian, Che Young Lee, Yan Zhou, Xin Zhao, Ciril Abraham, Wenbin Mo et al. · 2023 · Blood
64. Transcriptional regulation and T cell exhaustion
    Matthew H. Collins, Andrew J. Henderson · 2014 · Current Opinion in HIV and AIDS
65. Interleukin (IL)-7 Signaling in the Tumor Microenvironment
    Iwona S Bednarz-Misa, Mariusz A. Bromke, Małgorzata Krzystek‐Korpacka · 2021 · Advances in experimental medicine and biology
66. Chronic LCMV Infection Is Fortified with Versatile Tactics to Suppress Host T Cell Immunity and Establish Viral Persistence
    Caleb J. Studstill, Bumsuk Hahm · 2021 · Viruses
67. Generating Immunological Memory Against Cancer by Camouflaging Gold‐Based Photothermal Nanoparticles in NIR‐II Biowindow for Mimicking T ‐Cells
    Xuefan Xiong, Ying Zhang, Xinqi Huang, Shusheng Zhang, Qiong Li · 2024 · Small
68. Small Molecule Inhibition of Glycogen Synthase Kinase-3 in Cancer Immunotherapy
    Alison Taylor, Christopher E. Rudd · 2019 · Advances in experimental medicine and biology
69. Functional tumor specific CD8 + T cells in spleen express a high level of PD-1
    Zili Wang, Ting Chen, Wanzun Lin, Weili Zheng, Junying Chen, Fei Huang, Xianhe Xie · 2020 · International Immunopharmacology
70. CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead
    Nada Saed Homod Al Shaer, Ibraheem Masoud, Aya Tleyjeh, Attas Alawi Al-Attas, Maryam Alawi Al-Attas, Mohammed Imran Khan, Ahmed Yaqinuddin · 2026 · Frontiers in Immunology
71. Put in a “Ca2+ll” to Acute Myeloid Leukemia
    Clara Lewuillon, Marie-Océane Laguillaumie, Bruno Quesnel, Thierry Idziorek, Yasmine S. Touil, Loïc Lemonnier · 2022 · Cells
72. Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity
    Katherine A. Waugh, Sonia M. Leach, Jill E. Slansky · 2015 · Vaccines
73. Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
    Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno T Pruijm, Solange Peters, Roger Hullin et al. · 2024 · Nature Communications
74. Znaczenie receptora programowanej śmierci 1 oraz jego ligandów w układzie immunologicznym oraz nowotworach
    Maciej Grzywnowicz, Krzysztof Giannopoulos · 2012 · Acta Haematologica Polonica
75. Epigenetics behind CD8+ T cell activation and exhaustion
    Hao Zu, Xiaoqin Chen · 2024 · Genes and Immunity
76. Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity
    Lih‐Yun Hsu, James Todd Rosenbaum, Erik J. Verner, William B. Jones, Craig M. Hill, James W. Janc, Joseph J. Buggy, Rahul D. Pawar, Poorva Ghosh, Dan Li et al. · 2024 · npj Drug Discovery.
77. CD8+ T cell-based immunotherapy: Promising frontier in human diseases
    Nu Quynh Chau Ton, Gitima Deka, Pil‐Hoon Park · 2025 · Biochemical Pharmacology
78. Expression regulation and function of PD-1 and PD-L1 in T lymphoma cells
    Maria Y. Liu, John David Klement, Candace J. Poole, Jan van Riggelen, Kebin Liu · 2021 · Cellular Immunology
79. PD-1+ CD4 T cell immune response is mediated by HIF-1α/NFATc1 pathway after P. yoelii infection
    Haixia Wei, Anqi Xie, Jiajie Li, Chao Fang, Lin Liu, Junmin Xing, Feihu Shi, Feng Mo, Dianhui Chen, Hongyan Xie et al. · 2022 · Frontiers in Immunology
80. CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells
    Liwei Ren, Ziyin Li, Yu Zhou, Jun Zhang, Ziheng Zhao, Zhaofei Wu, Ye Zhao, Yurong Ju, Xuewen Pang, Xiuyuan Sun et al. · 2023 · Molecular Oncology
81. The role of cytotoxic T cells in IgG4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease
    Tetsuya Tabeya, Motohisa Yamamoto, Yasuyoshi Naishiro, Keisuke Ishigami, Yui Shimizu, Hidetaka Yajima, Chisako Suzuki, Nobuhiko Seki, Kenichi Takano, Tetsuo Himi et al. · 2014 · Modern Rheumatology
82. PD-1 Upregulation Is Associated with Exhaustion of Regulatory T Cells and Reflects Immune Activation in HIV-1-Infected Individuals
    Jian Xiao, Lifeng Zhang, Yuan Dong, Xian Liu, Lishan Peng, Yang Yang, Ying Wang · 2019 · AIDS Research and Human Retroviruses
83. AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enhanced anti-tumor immunity and diminished toxicity
    Fan Ye, Jianing Huang, Xiaoli Cheng, Shih Chieh Chen, Fang Huang, Wen-Chin Huang, Botong Hua, Ella Li, Jenny Z. Jiang, Hanna Lin et al. · 2025 · Frontiers in Immunology
84. TMEM41B is an endoplasmic reticulum Ca2+ release channel maintaining naive T cell quiescence and responsiveness
    Yuying Ma, Yi Wang, Xiaocui Zhao, Gang Jin, Jing Xu, Zhuoyang Li, Na Yin, Zhaobing Gao, Bingqing Xia, Min Peng · 2025 · Cell Discovery
85. Immune Checkpoint Molecules in Hodgkin Lymphoma and Other Hematological Malignancies
    Mohamed Nazem Alibrahim, Antonino Carbone, Noor Alsaleh, Annunziata Gloghini · 2025 · Cancers
86. Resident Memory T Cells in the Tumor Microenvironment
    Jason B. Williams, Thomas Seth Kupper · 2020 · Advances in experimental medicine and biology
87. IL-6/STAT3 Signaling Axis Enhances and Prolongs Pdcd1 Expression in Murine CD8 T Cells
    Michael Duane Powell, Peiyuan Lu, Dennis Kyle Neeld, Anna K. Kania, Lou-Ella George-Alexander, Alexander P. R. Bally, Christopher D. Scharer, Jeremy M. Boss · 2022 · ImmunoHorizons
88. Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer
    Wan‐Ting Kuo, I‐Ying Kuo, Hung-Chia Hsieh, Ssu-Ting Wu, Wu‐Chou Su, Yi‐Ching Wang · 2024 · Journal of Biomedical Science
89. PD-1/PD-L1 pathway inhibition to restore effector functions in exhausted CD8+ T cells: chances, limitations and potential risks
    Priya Veluswamy, Dunja Bruder · 2018 · Translational Cancer Research
90. Rational design of a Nivolumab-based ANTI-PD-1 single chain variable fragment that blocks the interaction between PD-1 expressed on T-CELLS and PD-L1 ON CHO cells
    Jong Shin, Siavash Raissi, Paul Phelan, Peter A. Bullock · 2022 · Protein Expression and Purification
91. Cumulative effects of weakly repressive regulatory regions in the 3’ UTR maintain PD-1 expression homeostasis in mammals
    Xiaoqian Lai, Rong Li, Panpan Wang, Meng Li, Chenxi Xiao, Qiang Cao, Xin Li, Wenxue Zhao · 2023 · Communications Biology
92. Relationship between T cell receptor clonotype and PD‐1 expression of tumor‐infiltrating lymphocytes in colorectal cancer
    Kenta Sukegawa, Kiyomi Shitaoka, Hiroshi Hamana, Eiji Kobayashi, Yoshihiro Miyahara, Keisuke Fujii, Kei Tsuda, Shiori Saeki, Takuya Nagata, Tatsuhiko Ozawa et al. · 2020 · European Journal of Immunology
93. Epigenetic mechanisms of liver tumor resistance to immunotherapy
    Julie Sanceau, Angélique Gougèlet · 2021 · World Journal of Hepatology
94. Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells
    Catarina Sacristán, Ben Youngblood, Peiyuan Lu, Alexander P. R. Bally, Jean Xu, Katelyn McGary, Susannah L. Hewitt, Jeremy M. Boss, Jane A. Skok, Rafi Ahmed et al. · 2024 · Cell Reports
95. miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape
    Fang Chen, Dandan Zhao, Yongfang Xu, Yi qin Zhang, Min-Hsuan Chen, Khyatiben V. Pathak, Nate Hansen, Brooke Lovell, Yong H. Liang, Katrina Estrella et al. · 2025 · Nature Communications
96. Transcription factor IRF-5 regulates lipid metabolism and mitochondrial function in murine CD8+ T-cells during viral infection
    Linh Thuy Mai, Sharada Swaminathan, Trieu Hai Nguyen, Étienne Collette, Tania Charpentier, Liseth Carmona‐Pérez, Hamza Loucif, Alain Lamarre, Krista M. Heinonen, David Langlais et al. · 2025 · The EMBO Journal
97. Leveraging T cells for cancer immunotherapy
    Adam Bates, Nicole E. Fletcher, Fei Gao, Mariana Pereira Pinho, Tao Dong · 2025 · Immunity & Inflammation
98. Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1
    Hue Tu Quach, Zhaohua Hou, Rebecca Y. Bellis, Jasmeen K. Saini, Alfredo Amador-Molina, Prasad S. Adusumilli, Yuquan Xiong · 2022 · Expert Opinion on Investigational Drugs
99. Homeostatic PD-1 signaling restrains EOMES-dependent oligoclonal expansion of liver-resident CD8 T cells
    Marie Le Moine, Abdulkader Azouz, Guillem Sanchez Sanchez, Solange Dejolier, Muriel Nguyen, Séverine Thomas, Valdrin Shala, Hacene Dreidi, Sébastien Denanglaire, Frédérick Libert et al. · 2023 · Cell Reports
100. Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs
     Simin Ahmadvand, Lotf-Ali Norouzi, Yousef Mohammadi, Akbar Safaei, Bijan Khademi, Maziar Motiee‐Langroudi, Abbas Ali Ghaderi · 2024 · BMC Immunology